FIELD: medicine; urology.
SUBSTANCE: drug is introduced into urethra and bladder in the following content of substances per 20 ml of distilled water: 1,3-diethylbenzimedazolium triiodide—0.1 g, polyvinylpyrrolidone—0.1 g.
EFFECT: method enables the active substance to be uniformly distributed by gravity along the lower urinary tract, enables to achieve complete elimination of bacteria from the infectious inflammation center in the lower urinary tract, which provides complete recovery of the patient.
1 cl, 1 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING AND PREVENTING URINATION DISORDERS | 2019 |
|
RU2708524C1 |
METHOD OF TREATMENT AND PREVENTION OF RADIATION CYSTITIS | 2019 |
|
RU2730450C1 |
METHOD OF TREATING PATIENTS WITH CHRONIC RECURRENT BACTERIAL CYSTITIS | 2023 |
|
RU2820135C1 |
METHOD OF TREATING CHRONIC CYSTITIS | 2010 |
|
RU2452535C1 |
METHOD OF TREATING THE NEUROGENIC BLADDER | 2020 |
|
RU2743805C1 |
METHOD OF TREATING INTERSTITIAL CYSTITIS USING MEDICINAL COMPOSITIONS | 2023 |
|
RU2824705C1 |
METHOD FOR TREATMENT AND PREVENTION OF CYSTITIS | 2020 |
|
RU2751649C1 |
MEANS FOR THE TREATMENT OF UROLITHIASIS IN CARNIVORES | 2018 |
|
RU2680087C1 |
METHOD OF TREATING RADIATION AND INTERSTITIAL CYSTITIS | 2014 |
|
RU2557949C1 |
PREVENTIVE METHOD OF POST-CITTAL CYSTITIS | 2017 |
|
RU2648443C1 |
Authors
Dates
2024-06-28—Published
2023-03-31—Filed